Evidence map›Paper›PMID 23579201›Full record

ArticleFly

The effect of JIL-1 on position-effect variegation is proportional to the total amount of heterochromatin in the genome.

Jack Girton, Chao Wang, Jørgen Johansen, Kristen M Johansen

Open access · hybridAbstract read
In one paragraph

Article in Fly. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Jack GirtonDepartment of Biochemistry, Biophysics and Molecular Biology, Iowa State University, Ames, IA, USA. bpatch@iastate.edu
Chao Wang
Jørgen Johansen
Kristen M Johansen
Institute of Molecular Biology and Biophysics · RUIowa State University · US

Funding

Regulation of Chromatin Structure byPhosphorylationR01GM062916 · NIGMS · IOWA STATE UNIVERSITY · PI JOHANSEN, JORGEN, JOHANSEN, KRISTEN M · 2001 to 2014
$3.5M
NIGMS NIH HHS GM062916NIGMS NIH HHS R01 GM062916
6 · The paper itself

Abstract

In this study we have taken advantage of recent whole genome sequencing studies that have determined the DNA content in the heterochromatic regions of each Drosophila chromosome to directly correlate the effect on position-effect variegation of a pericentric insertion reporter line, 118E-10 with the total amount of heterochromatic DNA. Heterochromatic DNA levels were manipulated by adding or subtracting a Y chromosome as well as by the difference in the amount of pericentric heterochromatin between the X and Y chromosome. The results showed a direct, linear relationship between the amount of heterochromatic DNA in the genome and the expression of the w marker gene in the 118E-10 pericentric reporter line and that increasing amounts of heterochromatic DNA resulted in increasing amounts of pigment/gene activity. In Drosophila heterochromatic spreading and gene silencing is counteracted by H3S10 phosphorylation by the JIL-1 kinase, and we further demonstrate that the haplo-enhancer effect of JIL-1 is proportional to the amount of total heterochomatin, suggesting that JIL-1's activity is dynamically modulated to achieve a more or less constant balance depending on the levels of heterochromatic factors present.

Indexed as

Chromosomal Position EffectsGenome, InsectHeterochromatinAnimalsChromosomes, InsectDrosophila melanogasterDrosophila ProteinsFemaleMaleProtein Serine-Threonine KinasesDrosophila ProteinsHeterochromatinJIL-1 protein, DrosophilaProtein Serine-Threonine KinasesDrosophilagene silencingheterochromatinJIL-1 kinasePEV

Identifiers

PMID23579201
PMCPMC3732332
OpenAlexW2147167158

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.